Palisade Bio (PALI) Prepaid Assets (2010 - 2026)

Palisade Bio's (PALI) quarterly Prepaid Assets came in at $615000.0 in Q1 2026, down 6.39% year-on-year from $657000.0 in Q1 2025, and down 26.44% on a QoQ basis from $836000.0 in Q4 2025.

Palisade Bio (PALI) Prepaid Assets (2010 - 2026) Analysis & Trends

Palisade Bio (PALI) has 17 years of Prepaid Assets data on file, last reported at $615000.0 in Q1 2026.

  • On a quarterly basis, Prepaid Assets fell 6.39% year-over-year to $615000.0 in Q1 2026; TTM through Mar 2026 was $615000.0, a 6.39% decrease from a year earlier, with the FY2025 full-year figure at $836000.0, up 24.22% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $615000.0, down from $836000.0 in the prior quarter.
  • Over the last five years, Prepaid Assets for PALI reached as high as $2.4 million in Q4 2022 and fell as low as $5000.0 in Q3 2023.
  • Historically, Prepaid Assets has averaged $760500.0 across 5 years, with a median of $717500.0 in 2023.
  • Across the five-year window, Prepaid Assets sank 99.57% in 2023 and jumped 16500.0% in 2024, its largest moves.
  • Year by year, Prepaid Assets stood at $2.4 million in 2022, then slumped by 61.87% to $896000.0 in 2023, then fell by 24.89% to $673000.0 in 2024, then rose by 24.22% to $836000.0 in 2025, then fell by 26.44% to $615000.0 in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $615000.0 in Q1 2026, $836000.0 in Q4 2025, and $445000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Palisade Bio 985.76 -132.63 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 615,000.00
Dec 31, 2025 836,000.00
Sep 30, 2025 445,000.00
Jun 30, 2025 5,000.00
Mar 31, 2025 657,000.00
Dec 31, 2024 673,000.00
Sep 30, 2024 830,000.00
Jun 30, 2024 5,000.00
Mar 31, 2024 294,000.00
Dec 31, 2023 896,000.00
Sep 30, 2023 5,000.00
Jun 30, 2023 1.01 Mn
Mar 31, 2023 762,000.00
Dec 31, 2022 2.35 Mn
Sep 30, 2022 1.17 Mn
Mar 31, 2022 1.61 Mn
Dec 31, 2021 28,000.00
Sep 30, 2021 17,000.00
Jun 30, 2021 2.01 Mn
Mar 31, 2021 1.31 Mn